MICA and NLRP3 gene polymorphisms interact synergistically affecting the risk of ankylosing spondylitis.

[1]  R. Sánchez-Sánchez,et al.  The interplay between HLA-B and NLRP3 polymorphisms may be associated with the genetic susceptibility of gout , 2022, Molecular Biology Reports.

[2]  Xiangyu Wang,et al.  Relationship Between IL1 Gene Polymorphism and Susceptibility to Ankylosing Spondylitis: An Updated and Supplemented Meta-Analysis , 2021, Biochemical Genetics.

[3]  R. Sánchez-Sánchez,et al.  A proposed HLA-B*27 screening method for ankylosing spondylitis detection based on tag-single nucleotide polymorphisms: a preliminary study , 2021, Molecular Biology Reports.

[4]  Wangen Li,et al.  NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases , 2021, Frontiers in Immunology.

[5]  Joohee Jung,et al.  NLRP3 Deficiency in Hepatocellular Carcinoma Enhances Surveillance of NK-92 through a Modulation of MICA/B , 2021, International journal of molecular sciences.

[6]  Douglas J. Matthies,et al.  Major Histocompatibility Complex Class I-Related Chain A (MICA) Allelic Variants Associate With Susceptibility and Prognosis of Gastric Cancer , 2021, Frontiers in Immunology.

[7]  J. Rosenbaum,et al.  Putative Pathobionts in HLA-B27-Associated Spondyloarthropathy , 2021, Frontiers in Immunology.

[8]  M. Brown,et al.  Inflammasome Activation in Ankylosing Spondylitis Is Associated With Gut Dysbiosis , 2021, Arthritis & rheumatology.

[9]  I. Peláez-Ballestas,et al.  Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis , 2021, Advances in Rheumatology.

[10]  L. Bi,et al.  Role of the NLRP3 inflammasome in autoimmune diseases. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  K. Bogunia-Kubik,et al.  Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis , 2020, The Pharmacogenomics Journal.

[12]  P. Emery,et al.  Recent advances in ankylosing spondylitis: understanding the disease and management , 2018, F1000Research.

[13]  Chen Zhao,et al.  The association of NLRP3 and TNFRSF1A polymorphisms with risk of ankylosing spondylitis and treatment efficacy of etanercept , 2017, Journal of clinical laboratory analysis.

[14]  M. Bicalho,et al.  MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome? , 2017, Front. Immunol..

[15]  F. Eren,et al.  Association of ERAP1, IL23R and PTGER4 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis , 2017, The open rheumatology journal.

[16]  Xiaodong Zhou,et al.  Associations of MICA Polymorphisms with Inflammatory Rheumatic Diseases , 2015, The open rheumatology journal.

[17]  U. Vogel,et al.  Genetic Variations in Pattern Recognition Receptor Loci Are Associated with Anti-TNF Response in Patients with Rheumatoid Arthritis , 2015, PloS one.

[18]  Jian-hua Xu,et al.  Associations between ERAP1 polymorphisms and ankylosing spondylitis susceptibility: An updated meta-analysis , 2015, Modern rheumatology.

[19]  Y. H. Lee,et al.  Meta-analysis of the association between functional MICA-TM polymorphisms and systemic lupus erythematosus, rheumatoid arthritis and ankylosing spondylitis , 2015, Zeitschrift für Rheumatologie.

[20]  J. Reveille.  An update on the contribution of the MHC to as susceptibility , 2014, Clinical Rheumatology.

[21]  P. Söderkvist,et al.  Genetic variants in CARD8 but not in NLRP3 are associated with ankylosing spondylitis , 2013, Scandinavian journal of rheumatology.

[22]  T. Merriman,et al.  Prevalence of HLA-B27 in the New Zealand population: effect of age and ethnicity , 2013, Arthritis Research & Therapy.

[23]  P. Scheet,et al.  MICA, a gene contributing strong susceptibility to ankylosing spondylitis , 2013, Annals of the rheumatic diseases.

[24]  Y. Lee,et al.  The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis. , 2012, Joint, bone, spine : revue du rhumatisme.

[25]  M. Brown,et al.  Is there a higher genetic load of susceptibility loci in familial ankylosing spondylitis? , 2012, Arthritis care & research.

[26]  Paul Weston,et al.  Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility , 2011, Nature Genetics.

[27]  T. Merriman,et al.  Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease , 2010, Genes and Immunity.

[28]  M. Phipps,et al.  MICA polymorphism: biology and importance in immunity and disease. , 2010, Trends in molecular medicine.

[29]  Michael M. Ward,et al.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci , 2010, Nature Genetics.

[30]  P. Donnelly,et al.  Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants , 2007, Nature Genetics.

[31]  Jason H. Moore,et al.  Power of multifactor dimensionality reduction for detecting gene‐gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity , 2003, Genetic epidemiology.

[32]  C. Yee,et al.  Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation , 2002, Nature.

[33]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[34]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.

[35]  Judith A. Smith.  Update on Ankylosing Spondylitis: Current Concepts in Pathogenesis , 2014, Current Allergy and Asthma Reports.

[36]  R. Elston,et al.  Odds ratio based multifactor-dimensionality reduction method for detecting gene-gene interactions , 2007, Bioinform..